Default company panoramic image

Ennaid Therapeutics

We are developing a cure against all 4 strains of dengue virus using a patented technology that shows >99% inhibition of the virus.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Atlanta, GA, USA
  • Currency USD
  • Founded September 2012
  • Employees 7
  • Website

Company Summary

We are developing a cure against all four strains of dengue virus, a mosquito-borne virus that infects 400 million in the tropics each year & of which 2.5 billion people worldwide are at risk of contracting. There is currently no drug or vaccine available. The development of our cure will stop a fast-growing pandemic, making a positive impact on global health. We will later use the same technology to develop a cure for west nile virus, also.


  • Default avatar
    Adrian Barfield
    Business Advisor/Consultant

    Adrian is the founder of Barfield Consulting Group advising companies on raising start-up capital & building equity. Formerly at BMS & Lilly, he led the US Commercial operations Oncology Business & is a serial entrepreneur holding positions at Medical Media Holdings, Tiba Oncology and P4 Therapeutics, Adrian will advise Ennaid in raising capital and/or partnering with Pharmaceutical companies. He holds a B.S. in Natural Science from UT, Austin.

  • Default avatar
    Romeo Ibrahim
    Scientific Advisor

    With greater than 17 years experience in the pharma industry Romeo is a stellar scientist and has worked in big pharma and small start up companies. His expertise is in basic chemistry, tech transfer, process development and optimization, scale-up and validation. He has many years of experience managing outsourced development project relations. Romeo has a Masters in Chemical Engineering from University of Illinois, Chicago and a BS in Chemistry.

  • Default avatar
    Thandi Myeni
    Public Health/Medical Advisor

    Thandeka Myeni MD MPH, has a background in both business and medicine. In addition to having a history in sales and logistics, she is an ophthalmologist who has completed advanced specialty training in both the medical and surgical management of glaucoma. Dr. Myeni received her undergraduate degree from the esteemed Amherst College. She received her Doctor of Medicine degree from the Medical College of Georgia. Thereafter she acquired a Master

  • Default avatar
    Darnisha Grant Harrison
    President & CEO

    Biopharmaceutical entrepreneur with 18 yrs experience in Life Sciences. Post days as a Scientist, she has 15 years in Business Development in pharma and is expert in increasing revenues in the pharma services and products sector by identifying, negotiating/closing outsourced deals, drug development deals and strategic partnerships. Expertly skilled in business planning and execution of such plans. B.S. in Microbiology, Minor Chemistry, from LSU.

  • Default avatar
    Robert Garry
    Chief Scientific Officer

    Robert Garry, Ph.D., is the inventor of our technology and is a world-renowned Microbiologist and Immunologist. Research in his laboratory focuses on a number of aspects of retroviral pathogenesis and molecular characterization of isolates of HIV molecules.

  • Default avatar
    Jared Genser
    Government Affairs Advisor

    Jared is Managing Director of Perseus Strategies, LLC, a law and consulting firm focused on serving clients in global health, international human rights, and corporate social responsibility. He has served as outside counsel to such organizations as the Bill & Melinda Gates Foundation and Friends of the Global Fight Against AIDS, Tuberculosis, and Malaria. His human-rights clients have included former Czech Republic President Václav Havel and Nobe

  • Default avatar
    George Davis
    Corporate Affairs

    George has greater than twenty years in business consulting, advising successful startups and small businesses, business development, corporate affairs, strategic planning, inbound marketing and social media deployment in software and new emerging technologies. He equally has an extensive network both domestically and internationally. He holds a B. S. from Virginia Tech University in Business Administration with a concentration in Hospitality and


  • Default avatar
    Michael Horten
    Default avatar
    11d2ff6a 0a3b 46d6 a16f ebb99e0ac060
    Business Advisor

Previous Investors

  • Default avatar